<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>N-[3-[[[(1S)-4-(5-Amino-2-<z:chebi fb="0" ids="51635">pyridinyl</z:chebi>)-1-[[4-difluoromethylene)-1-piperidinyl]<z:chebi fb="1" ids="23019">carbonyl</z:chebi>]butyl]amino]<z:chebi fb="0" ids="29825">sulfonyl</z:chebi>][<z:chebi fb="0" ids="17097">1,1'-biphenyl</z:chebi>]-2-yl]<z:chebi fb="0" ids="27856">acetamide</z:chebi> <z:chebi fb="16" ids="36807">hydrochloride</z:chebi> (SSR182289A) is a novel, potent, and selective thrombin inhibitor </plain></SENT>
<SENT sid="1" pm="."><plain>We have examined the antithrombotic properties of SSR182289A administered by i.v. and p.o. routes in several different animal <z:mp ids='MP_0005048'>thrombosis</z:mp> models in comparison with reference antithrombotic agents </plain></SENT>
<SENT sid="2" pm="."><plain>Oral administration of SSR182289A produced dose-related antithrombotic effects in the following models; rat <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> (ED(50) 0.9 mg/kg p.o.), rat silk thread arterio-venous (AV) shunt (ED(50) 3.8 mg/kg p.o.), rat thromboplastin-induced AV shunt (ED(50) 3.1 mg/kg p.o.), rat carotid artery <z:mp ids='MP_0005048'>thrombosis</z:mp> (ED(200) 5.9 mg/kg p.o.), and rabbit <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> (ED(50) 7.5 mg/kg p.o.) </plain></SENT>
<SENT sid="3" pm="."><plain>Administered as an i.v. bolus, SSR182289A showed antithrombotic activity in the above models with ED(50)/ED(200) values in the range of 0.2 to 1.9 mg/kg i.v </plain></SENT>
<SENT sid="4" pm="."><plain>SSR182289A increased rat tail transection <z:mp ids='MP_0001914'>bleeding</z:mp> time at doses &gt; or =10 mg/kg p.o </plain></SENT>
<SENT sid="5" pm="."><plain>In the rat thromboplastin-induced AV shunt model, SSR182289A 10 mg/kg p.o. produced marked antithrombotic effects at 30, 60, 120, and 240 min after administration </plain></SENT>
<SENT sid="6" pm="."><plain>Hence, SSR182289A demonstrates potent oral antithrombotic properties in animal venous, AV-shunt, and <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> models </plain></SENT>
</text></document>